7Baggers
 Published on: 2025-11-16 14:29:14  newser.com Sun, 16 Nov 2025 20:29:14 GMT
 Marker Therapeutics reports Q3 EPS (12c) vs (26c) last year  TipRanks Fri, 14 Nov 2025 20:11:24 GMT
 Marker Therapeutics : Corporate Presentation  MarketScreener Fri, 14 Nov 2025 14:45:10 GMT
 Marker Therapeutics Q3 net loss narrows to $2 mln  TradingView Fri, 14 Nov 2025 12:10:18 GMT
 Marker Therapeutics, Inc. SEC 10-Q Report  TradingView Thu, 13 Nov 2025 22:33:01 GMT
 published on: 2025-11-13 11:27:27  newser.com Thu, 13 Nov 2025 17:27:27 GMT
 marker therapeutics appoints kathryn penkus corzo to board of directors  Investing.com India Thu, 06 Nov 2025 01:29:19 GMT
 published on: 2025-11-05 16:59:44  fcp.pa.gov.br Wed, 05 Nov 2025 19:59:44 GMT
 Marker Therapeutics Appoints New Board Member  TradingView Wed, 05 Nov 2025 12:45:00 GMT
 Marker Therapeutics Strengthens Board with New Appointment  TipRanks Wed, 05 Nov 2025 08:00:00 GMT
 marker therapeutics appoints penkus corzo to board of directors  TipRanks Wed, 05 Nov 2025 08:00:00 GMT
 [form 4] marker therapeutics, inc. insider trading activity  Stock Titan Tue, 04 Nov 2025 22:09:13 GMT
 Marker Therapeutics Announces Upcoming Presentations on  GlobeNewswire Mon, 03 Nov 2025 08:00:00 GMT
 published on: 2025-11-03 00:22:23  newser.com Mon, 03 Nov 2025 06:22:23 GMT
 published on: 2025-10-29 06:15:46  newser.com Wed, 29 Oct 2025 11:15:46 GMT
 published on: 2025-10-29 03:27:17  newser.com Wed, 29 Oct 2025 08:27:17 GMT

Marker Therapeutics, Inc
(NASDAQ:MRKR) 

MRKR stock logo

Marker Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Its MultiTAA-specific T cell technolog...

Founded: 1992
Full Time Employees: 28
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends